कृपया अन्य खोज का प्रयास करें
Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human single-chain version of interleukin 12 that is in Phase 1b/2a clinical trial for the treatment of solid tumor indications, including ovarian cancer, non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6, which is in Phase 1b/I2a clinical trail to treat chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy; and SON-1210, a bispecific compound for solid tumor indications, including colorectal cancer. It has a license agreement with New Life Therapeutics Pte, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6. The company is headquartered in Princeton, New Jersey.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Raghu Rao | 59 | 2019 | Independent Director |
Jason Bock | - | - | Member of Scientific Advisory Board |
Guido Cavaletti | - | - | Member of Scientific Advisory Board |
Hossein Borghaei | - | - | Member of Scientific Advisory Board |
Nailesh Bhatt | 49 | 2018 | Independent Director |
Albert D. Dyrness | 59 | 2019 | Independent Director |
Robert Wenham | - | 2022 | Member of Scientific Advisory Board |
Lori McNeill | - | 2022 | Director |
Donald J. Griffith | 74 | 2015 | Controller & Director |
Pankaj Mohan | 58 | 2015 | Founder, Chairman, CEO & President |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है